Contrast-enhanced ultrasound and super-resolution imaging to predict kidney function after nephrectomy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will enroll about 285 adults with renal cell carcinoma who are scheduled for partial or radical nephrectomy and perform contrast-enhanced ultrasound (CEUS) and super-resolution imaging (SRI) before and at multiple time points after surgery. They will quantify microcirculation and microvascular structure in the operated kidney and compare those measures with the contralateral healthy kidney over time. Primary outcomes include long-term renal function (new baseline eGFR after radical nephrectomy and recovery from ischemia after partial nephrectomy) and the occurrence, severity, and early recovery of postoperative acute kidney injury (AKI). Imaging biomarkers will be combined with clinical variables to build predictive models tailored to different surgical methods.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Fully understood and voluntarily signed the informed Consent Form (ICF);
* Age: \> 18 (at the time of signing the informed consent form); Gender is not limited.
* Preoperative eGFR \> 45ml/min/1.73m2 (corrected CKD-EPI formula);
* After the clinician formulates the treatment plan and communicates with the patient, they decide whether to perform radical nephrectomy or partial nephrectomy.
* ECOG score: 0-2 points;
* Be willing and able to abide by the visits, treatments, laboratory tests and other procedures of the research plan.

Exclusion Criteria:

* Patients with solitary kidney or severe contralateral renal insufficiency (eGFR \< 15ml/min/1.73m2);
* Preoperative reliance on renal replacement therapy (such as dialysis, etc.);
* Those who fail to complete the nephrectomy as planned during the operation;
* Patients with lymph node metastasis, distant metastasis or venous tumor thrombus;
* The healthy kidney has undergone radiotherapy, ablation or other surgeries.
* Have a history of allergy to ultrasound contrast agents;
* Have any contraindications for contrast-enhanced ultrasound, such as right-to-left shunt, severe pulmonary hypertension, etc.
* Patients with hemodynamic instability, including those with persistent hypotension (blood pressure \< 90/60 MMHG), uncontrollable heart failure, active bleeding (such as gastrointestinal and cerebral hemorrhage, etc.), or those with a bleeding tendency and hemoglobin \< 60g/L and/or platelet count \< 50×109/L;
* Accompanied by structural abnormalities of the urinary system or functional abnormalities that cannot be corrected in a short time (such as duplicate kidneys, polycystic kidneys, horseshoe kidneys, isolated kidneys, renal artery stenosis \> 50%, urinary tract obstruction, and previous history of kidney surgery, etc.), long-term indwelling of urinary catheters, etc.
* There are other diseases that limit life expectancy to less than six months;
* Previous (≤30 days before randomization) or concurrent participation in another clinical study.

Where it's running

• Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University
  Nanjing, Jiangsu, China Recruiting

Study contacts

• Study coordinator: Le Qu
• Email: septsoul@hotmail.com
• Phone: +86 15720625951

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Recovery, quality of life, and physical function after partial or radical nephrectomy

  This study tests recovery, quality of life, and physical function before and after nephrectomy to see how patients fare depending on the surgery type.

  Recruiting Herlev and Gentofte Hospital · Herlev · NCT07908277

• Pain management plan implementation for major open abdominal surgeries

  This trial tests an opioid-epidural pain management approach to see if it improves post-surgical pain control for adults undergoing open abdominal procedures like colectomy, hepatectomy, and nephrectomy.

  Recruiting National and Kapodistrian University of Athens · Athens, Athens · NCT07901582

• SP16 to help prevent kidney injury during cardiac surgery in people with CKD

  Researchers are testing SP16 to see if it can prevent acute kidney injury in adults with chronic kidney disease who are having heart surgery that uses a heart-lung machine.

  Recruiting Phase 2 University of Erlangen-Nürnberg Medical School · Erlangen, Bavaria · NCT07661940

• ESP vs EXORA blocks after laparoscopic nephrectomy

  This observational study compares two pain-control blocks (ESP and EXORA) used after laparoscopic kidney removal to see which provides better pain relief and recovery.

  Recruiting Bakirkoy Dr. Sadi Konuk Research and Training Hospital · Istanbul, Istanbul · NCT07640282

• Fluid balance guided by mVExUS in ICU patients on CRRT with acute kidney injury

  This trial tests whether using modified venous excess ultrasound (mVExUS) to guide fluid removal in ICU patients on CRRT with AKI can achieve a better fluid balance in the first 72 hours compared with standard care.

  Recruiting Chulalongkorn University · Bangkok and 1 other locations · NCT07346118

• Outpatient recovery after acute kidney injury that required dialysis

  This pilot will test whether measuring residual kidney function at hospital discharge and sharing that information with patients and their outpatient nephrologists, plus guidance on monitoring and considering twice-weekly dialysis, helps adults who had acute kidney injury and still need dialysis after leaving the hospi

  Recruiting University of California, San Francisco · San Francisco, California · NCT07106151

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.